Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, and ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...

Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...

Researchers at the (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites.

Scientists explore how the immune and nervous systems constantly communicate, influencing brain diseases, behavior, and ...

Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders ...

That's because antibodies made in response to the vaccine can still offer some protection. There are, however, things that do affect your immune system. Medications like chemotherapy or infections ...

Immunologist and surgeon Yongxiang Zhao at Guangxi Medical University in Nanning, China, wondered whether he could harness this runaway immune response and direct it against tumours. To do so ...